Biocure Technology Inc. Enters into Exclusive Letter Agreement to Acquire Atriva Therapeutics GmbH in Reverse Takeover Transaction
(marketscreener.com) Biocure Technology Inc. announces that it has entered into an exclusive letter agreement dated September 8, 2023 with Atriva Therapeutics GmbH. whereby the Company will acquire all of the issued and outstanding securities of Atriva . The …
Vancouver, British Columbia–(Newsfile Corp. – September 18, 2023) – Biocure Technology Inc. (CSE: CURE) (“CURE” or the “Company”) announces that it has entered into an exclusive letter agreement dat…